Specific forms of BAFF favor BAFF receptor-mediated epithelial cell survival

Journal of Autoimmunity

Volumn 51, Issue , 2014, Pages 30-37

  Lahiri, Ayan ^a   Varin, Marie Michèle ^a   Le Pottier, Laëtitia ^a   Pochard, Pierre ^a   Bendaoud, Boutahar ^a   Youinou, Pierre ^a   Pers, Jacques Olivier ^a  

^a Universite de Brest   (France)

Author keywords

BAFF; BR3; Epithelial cells; Protein kinase C ; Salivary glands; Sj gren's syndrome

Indexed keywords

B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; BLOCKING ANTIBODY; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; TNFSF13B PROTEIN, HUMAN;

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; B LYMPHOCYTE; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND; SJOEGREN SYNDROME; ANTAGONISTS AND INHIBITORS; BIOPSY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; APOPTOSIS; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; BIOPSY; CELL SURVIVAL; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 84901269992     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.02.004     Document Type: Article

References (47)

1. Youinou P., Haralampos M. Moutsopoulos: a lifetime in autoimmunity. JAutoimmun 2010, 35:171-175.
2. Giroux M., Schmidt M., Descoteaux A. IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha. JImmunol 2003, 171:4187-4194.
3. Germain R.N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994, 76:287-299.
4. Hayashi Y., Arakaki R., Ishimaru N. Salivary gland and autoimmunity. JMed Invest 2009, 56(Suppl.):185-191.
5. Litinskiy M.B., Nardelli B., Hilbert D.M., He B., Schaffer A., Casali P., et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 2002, 3:822-829.
6. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. JExp Med 1999, 189:1747-1756.
7. Huard B., Arlettaz L., Ambrose C., Kindler V., Mauri D., Roosnek E., et al. BAFF production by antigen-presenting cells provides T cell co-stimulation. Int Immunol 2004, 16:467-475.
8. Vincent F.B., Saulep-Easton D., Figgett W.A., Fairfax K.A., Mackay F. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev 2013, 24:203-215.
9. Nardelli B., Belvedere O., Roschke V., Moore P.A., Olsen H.S., Migone T.S., et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 2001, 97:198-204.
10. Hase H., Kanno Y., Kojima M., Hasegawa K., Sakurai D., Kojima H., et al. BAFF/BLyS can potentiate B-cell selection with the B-cell coreceptor complex. Blood 2004, 103:2257-2265.
11. Gorelik L., Gilbride K., Dobles M., Kalled S.L., Zandman D., Scott M.L. Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. JExp Med 2003, 198:937-945.
12. Kern C., Cornuel J.F., Billard C., Tang R., Rouillard D., Stenou V., et al. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 2004, 103:679-688.
13. Moreaux J., Legouffe E., Jourdan E., Quittet P., Reme T., Lugagne C., et al. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 2004, 103:3148-3157.
14. Pers J.O., Daridon C., Devauchelle V., Jousse S., Saraux A., Jamin C., et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci 2005, 1050:34-39.
15. Daridon C., Devauchelle V., Hutin P., Le Berre R., Martins-Carvalho C., Bendaoud B., et al. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum 2007, 56:1134-1144.
16. Krumbholz M., Theil D., Derfuss T., Rosenwald A., Schrader F., Monoranu C.M., et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. JExp Med 2005, 201:195-200.
17. Thompson J.S., Bixler S.A., Qian F., Vora K., Scott M.L., Cachero T.G., et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 2001, 293:2108-2111.
18. Claudio E., Brown K., Park S., Wang H., Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol 2002, 3:958-965.
19. Qian Y., Qin J., Cui G., Naramura M., Snow E.C., Ware C.F., et al. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity 2004, 21:575-587.
20. Mecklenbrauker I., Kalled S.L., Leitges M., Mackay F., Tarakhovsky A. Regulation of B-cell survival by BAFF-dependent PKCdelta-mediated nuclear signalling. Nature 2004, 431:456-461.
21. DeVries-Seimon T.A., Ohm A.M., Humphries M.J., Reyland M.E. Induction of apoptosis is driven by nuclear retention of protein kinase C delta. JBiol Chem 2007, 282:22307-22314.
22. Varin M.M., Le Pottier L., Youinou P., Saulep D., Mackay F., Pers J.O. B-cell tolerance breakdown in Sjogren's syndrome: focus on BAFF. Autoimmun Rev 2010, 9:604-608.
23. Qian Y., Giltiay N., Xiao J., Wang Y., Tian J., Han S., et al. Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjogren's syndrome. Eur J Immunol 2008, 38:2219-2228.
24. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
25. Matassa A.A., Kalkofen R.L., Carpenter L., Biden T.J., Reyland M.E. Inhibition of PKCalpha induces a PKCdelta-dependent apoptotic program in salivary epithelial cells. Cell Death Differ 2003, 10:269-277.
26. Varin M.M., Guerrier T., Devauchelle-Pensec V., Jamin C., Youinou P., Pers J.O. In Sjogren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation. Autoimmun Rev 2012, 11:252-258.
27. Le Pottier L., Bendaoud B., Renaudineau Y., Youinou P., Pers J.O., Daridon C. New ELISA for B cell-activating factor. Clin Chem 2009, 55:1843-1851.
28. Shu H.B., Hu W.H., Johnson H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. JLeukoc Biol 1999, 65:680-683.
29. Tribouley C., Wallroth M., Chan V., Paliard X., Fang E., Lamson G., et al. Characterization of a new member of the TNF family expressed on antigen presenting cells. Biol Chem 1999, 380:1443-1447.
30. Fairfax K., Mackay I.R., Mackay F. BAFF/BLyS inhibitors: a new prospect for treatment of systemic lupus erythematosus. IUBMB Life 2012, 64:595-602.
31. Roschke V., Sosnovtseva S., Ward C.D., Hong J.S., Smith R., Albert V., et al. BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases. JImmunol 2002, 169:4314-4321.
32. Dillon S.R., Harder B., Lewis K.B., Moore M.D., Liu H., Bukowski T.R., et al. B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin. Arthritis Res Ther 2010, 12:R48.
33. Matassa A.A., Carpenter L., Biden T.J., Humphries M.J., Reyland M.E. PKCdelta is required for mitochondrial-dependent apoptosis in salivary epithelial cells. JBiol Chem 2001, 276:29719-29728.
34. Reyland M.E. Protein kinase Cdelta and apoptosis. Biochem Soc Trans 2007, 35:1001-1004.
35. Park C.H., Kim K.T. Apoptotic phosphorylation of histone H3 on Ser-10 by protein kinase Cdelta. PLoS One 2012, 7:e44307.
36. Le Pottier L., Devauchelle V., Fautrel A., Daridon C., Saraux A., Youinou P., et al. Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells. JImmunol 2009, 182:3540-3547.
37. Christodoulou M.I., Kapsogeorgou E.K., Moutsopoulos H.M. Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome. JAutoimmun 2010, 34:400-407.
38. Tada S., Yasui T., Nakatsuji Y., Okuno T., Koda T., Mochizuki H., et al. BAFF controls neural cell survival through BAFF receptor. PLoS One 2013, 8:e70924.
39. Jung D.J., Bong J.J., Baik M. Extracellular proteinase inhibitor-accelerated apoptosis is associated with B cell activating factor in mammary epithelial cells. Exp Cell Res 2004, 292:115-122.
40. Strange R., Li F., Saurer S., Burkhardt A., Friis R.R. Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development 1992, 115:49-58.
41. Allen-Petersen B.L., Miller M.R., Neville M.C., Anderson S.M., Nakayama K.I., Reyland M.E. Loss of protein kinase C delta alters mammary gland development and apoptosis. Cell Death Dis 2010, 1:e17.
42. Kawakami A., Nakashima K., Tamai M., Nakamura H., Iwanaga N., Fujikawa K., et al. Toll-like receptor in salivary glands from patients with Sjogren's syndrome: functional analysis by human salivary gland cell line. JRheumatol 2007, 34:1019-1026.
43. Guerrier T., Le Pottier L., Devauchelle V., Pers J.O., Jamin C., Youinou P. Role of toll-like receptors in primary Sjogren's syndrome with a special emphasis on B-cell maturation within exocrine tissues. JAutoimmun 2012, 39:69-76.
44. Li J., Jeong M.Y., Bae J.H., Shin Y.H., Jin M., Hang S.M., et al. Toll-like receptor3-mediated induction of chemokines in salivary epithelial cells. Korean J Physiol Pharmacol 2010, 14:235-240.
45. Manoussakis M.N., Kapsogeorgou E.K. The role of intrinsic epithelial activation in the pathogenesis of Sjogren's syndrome. JAutoimmun 2010, 35:219-224.
46. Manoussakis M.N., Spachidou M.P., Maratheftis C.I. Salivary epithelial cells from Sjogren's syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation. JAutoimmun 2010, 35:212-218.
47. Nakamura H., Horai Y., Suzuki T., Okada A., Ichinose K., Yamasaki S., et al. TLR3-mediated apoptosis and activation of phosphorylated Akt in the salivary gland epithelial cells of primary Sjogren's syndrome patients. Rheumatol Int 2013, 33:441-450.